Anavex Life Sciences Corp.

Organization

New York, NY, US

Ticker Symbols

NASDAQ:AVXL

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Business Address
51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
Mailing Address
51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
State Location
NY
State of Incorporation
NV

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cardiac dysfunction
- Patent number 12,138,240
- Issue date Nov 12, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Patent number 11,896,590
- Issue date Feb 13, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 11,839,600
- Issue date Dec 12, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2-73 as a therapeutic for insomnia, anxiety, and agitation
- Patent number 11,813,242
- Issue date Nov 14, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A19-144, A2-73 and certain anticholinesterase inhibitor composition...
- Patent number 11,690,821
- Issue date Jul 4, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethan...
- Patent number 11,661,405
- Issue date May 30, 2023
- Anavex Life Sciences Corp.
- Linda Sharon Daintree
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Sigma-1 receptor agonist systolic blood pressure therapy
- Patent number 11,622,955
- Issue date Apr 11, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2-73 crystalline polymorph compositions of matter and methods of u...
- Patent number 11,498,908
- Issue date Nov 15, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 11,446,275
- Issue date Sep 20, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2-73 as a therapeutic for insomnia, anxiety, and agitation
- Patent number 11,337,953
- Issue date May 24, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anavex2-73 for the treatment of alzheimer's disease
- Patent number 11,103,478
- Issue date Aug 31, 2021
- Anavex Life Sciences Corp.
- Marco Cecchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cardiac dysfunction
- Patent number 11,071,723
- Issue date Jul 27, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethan...
- Patent number 10,966,952
- Issue date Apr 6, 2021
- Anavex Life Sciences Corp.
- Linda Sharon Daintree
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Analgesic therapeutic and method, 1-(3-4(((1 R,3S,5S)-adamantan-1-y...
- Patent number 10,933,062
- Issue date Mar 2, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 10,888,543
- Issue date Jan 12, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 10,507,196
- Issue date Dec 17, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A19-144, A2-73 and certain anticholinesterase inhibitor composition...
- Patent number 10,441,563
- Issue date Oct 15, 2019
- Anavex Life Sciences Corp.
- Missling U. Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's dis...
- Patent number 10,426,754
- Issue date Oct 1, 2019
- Anavex Life Sciences Corp.
- Marco Cecchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethan...
- Patent number 10,413,519
- Issue date Sep 17, 2019
- Anavex Life Sciences Corp.
- Linda Sharon Daintree
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Patent number 10,195,192
- Issue date Feb 5, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ANAVEX2-73 and certain anticholinesterase inhibitors composition an...
- Patent number 9,750,746
- Issue date Sep 5, 2017
- Anavex Life Sciences Corp.
- Alexandre Vamvakides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic pr...
- Patent number 9,180,106
- Issue date Nov 10, 2015
- Anavex Life Sciences Corp.
- Alexandre Vamvakides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPY SELECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20240417798
- Publication date Dec 19, 2024
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Publication number 20240156810
- Publication date May 16, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEURODEVELOPMENTAL DISORDER THERAPY
- Publication number 20240066003
- Publication date Feb 29, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY AND AGITATION
- Publication number 20240041818
- Publication date Feb 8, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...
- Publication number 20230301961
- Publication date Sep 28, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL FORMS OF TETRAHYDRO-N, N-DIMETHYL-2, 2-DIPHENYL-3-FURANMETH...
- Publication number 20230278973
- Publication date Sep 7, 2023
- Anavex Life Sciences Corp.
- Linda Sharon Daintree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...
- Publication number 20230142424
- Publication date May 11, 2023
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY
- Publication number 20230071766
- Publication date Mar 9, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENANTIOMERS OF A2-73, ANALOGUES, AND SIGMA AGONIST ACTIVITY
- Publication number 20230044710
- Publication date Feb 9, 2023
- Anavex Life Sciences Corp.
- Gervais Neliat
- G01 - MEASURING TESTING
Information Patent Application
NEURODEVELOPMENTAL DISORDER THERAPY
- Publication number 20220387373
- Publication date Dec 8, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION
- Publication number 20220347149
- Publication date Nov 3, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS
- Publication number 20220249427
- Publication date Aug 11, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
- Publication number 20220226278
- Publication date Jul 21, 2022
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS
- Publication number 20220142968
- Publication date May 12, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CARDIAC DYSFUNCTION
- Publication number 20220096424
- Publication date Mar 31, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurodevelopmental Disorder Therapy
- Publication number 20210228532
- Publication date Jul 29, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHAN...
- Publication number 20210220321
- Publication date Jul 22, 2021
- Anavex Life Sciences Corp.
- Linda Sharon Daintree
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Publication number 20210196708
- Publication date Jul 1, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY
- Publication number 20210186920
- Publication date Jun 24, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...
- Publication number 20210115004
- Publication date Apr 22, 2021
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION
- Publication number 20210085637
- Publication date Mar 25, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...
- Publication number 20210046038
- Publication date Feb 18, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurodevelopmental Disorder Therapy
- Publication number 20200246303
- Publication date Aug 6, 2020
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...
- Publication number 20200038365
- Publication date Feb 6, 2020
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anavex2-73 for the Treatment of Alzheimer's Disease
- Publication number 20200022943
- Publication date Jan 23, 2020
- Anavex Life Sciences Corp.
- Marco Cecchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHAN...
- Publication number 20190350892
- Publication date Nov 21, 2019
- Anavex Life Sciences Corp.
- Linda Sharon Daintree
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Publication number 20190167668
- Publication date Jun 6, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CARDIAC DYSFUNCTION
- Publication number 20190117615
- Publication date Apr 25, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEURODEVELOPMENTAL DISORDER THERAPY
- Publication number 20190022052
- Publication date Jan 24, 2019
- Anavex Life Science Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anavex2-73 for the Treatment of Alzheimer's Disease
- Publication number 20180360796
- Publication date Dec 20, 2018
- Anavex Life Sciences Corp.
- Marco Cecchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
86768671 - ANAVEX
- Serial number 86768671
- Registration number 5273729
- Filing date Sep 25, 2015
- Anavex Life Sciences Corp.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86768699 - ANAVEX
- Serial number 86768699
- Registration number 5332424
- Filing date Sep 25, 2015
- Anavex Life Sciences Corp.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
77372571 - SIGMACEPTOR
- Serial number 77372571
- Registration number 3915422
- Filing date Jan 15, 2008
- Anavex Life Sciences Corp.
- 42 - Scientific and technological services and research and design relating thereto

Anavex Life Sciences Corp.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Treatment of cardiac dysfunction

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

Neurodevelopmental disorder therapy

A2-73 as a therapeutic for insomnia, anxiety, and agitation

A19-144, A2-73 and certain anticholinesterase inhibitor composition...

Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethan...

Sigma-1 receptor agonist systolic blood pressure therapy

A2-73 crystalline polymorph compositions of matter and methods of u...

Neurodevelopmental disorder therapy

A2-73 as a therapeutic for insomnia, anxiety, and agitation

Anavex2-73 for the treatment of alzheimer's disease

Treatment of cardiac dysfunction

Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethan...

Analgesic therapeutic and method, 1-(3-4(((1 R,3S,5S)-adamantan-1-y...

Neurodevelopmental disorder therapy

Neurodevelopmental disorder therapy

A19-144, A2-73 and certain anticholinesterase inhibitor composition...

Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's dis...

Crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethan...

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

ANAVEX2-73 and certain anticholinesterase inhibitors composition an...

Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic pr...

Patents Applicationslast 30 patents

THERAPY SELECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

NEURODEVELOPMENTAL DISORDER THERAPY

A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY AND AGITATION

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...

CRYSTAL FORMS OF TETRAHYDRO-N, N-DIMETHYL-2, 2-DIPHENYL-3-FURANMETH...

A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

ENANTIOMERS OF A2-73, ANALOGUES, AND SIGMA AGONIST ACTIVITY

NEURODEVELOPMENTAL DISORDER THERAPY

A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION

ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS

OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT

ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS

TREATMENT OF CARDIAC DYSFUNCTION

Neurodevelopmental Disorder Therapy

CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHAN...

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...

A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...

Neurodevelopmental Disorder Therapy

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...

Anavex2-73 for the Treatment of Alzheimer's Disease

CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHAN...

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

TREATMENT OF CARDIAC DYSFUNCTION

NEURODEVELOPMENTAL DISORDER THERAPY

Anavex2-73 for the Treatment of Alzheimer's Disease

Trademarklast 30 trademarks

86768671 - ANAVEX

86768699 - ANAVEX

77372571 - SIGMACEPTOR